Rating Reporting: Wells Fargo Gives PAREXEL International Corporation (NASDAQ:PRXL) Lower Rating. Lost Its “Outperform” Rating

November 23, 2016 - By whatsonthorold

Rating Reporting: Wells Fargo Gives PAREXEL International Corporation (NASDAQ:PRXL) Lower Rating. Lost Its

PAREXEL International Corporation (NASDAQ:PRXL) Downgrade

In a a research report issued to clients on Wednesday morning, Wells Fargo downgraded shares of PAREXEL International Corporation (NASDAQ:PRXL) to a “Market Perform” rating from a “Outperform” rating.

PAREXEL International Corporation (NASDAQ:PRXL) Ratings Coverage

Out of 11 analysts covering Parexel International (NASDAQ:PRXL), 2 rate it a “Buy”, 1 “Sell”, while 8 “Hold”. This means 18% are positive. $78 is the highest target while $49 is the lowest. The $65.71 average target is 13.61% above today’s ($57.84) stock price. Parexel International has been the topic of 21 analyst reports since August 7, 2015 according to StockzIntelligence Inc. The stock has “Mkt Underperform” rating given by Avondale on Monday, January 25. Evercore upgraded the stock to “Buy” rating in Wednesday, January 6 report. The company was initiated on Tuesday, June 21 by Credit Suisse. The firm earned “Neutral” rating on Tuesday, September 6 by UBS. SunTrust downgraded PAREXEL International Corporation (NASDAQ:PRXL) on Friday, November 11 to “Hold” rating. The firm has “Market Perform” rating given on Wednesday, October 21 by Avondale. The rating was maintained by Deutsche Bank on Friday, October 28 with “Hold”. The firm has “Buy” rating given on Monday, March 28 by SunTrust. Deutsche Bank maintained the shares of PRXL in a report on Friday, August 7 with “Hold” rating. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has “Hold” rating given on Friday, November 11 by Suntrust Robinson.

About 587,485 shares traded hands. PAREXEL International Corporation (NASDAQ:PRXL) has declined 12.36% since April 21, 2016 and is downtrending. It has underperformed by 17.69% the S&P500.

Insitutional Activity: The institutional sentiment decreased to 1 in 2016 Q2. Its down 0.16, from 1.16 in 2016Q1. The ratio worsened, as 31 funds sold all PAREXEL International Corporation shares owned while 96 reduced positions. 45 funds bought stakes while 102 increased positions. They now own 46.71 million shares or 2.30% less from 47.81 million shares in 2016Q1.

Qs Lc accumulated 0.02% or 30,252 shares. Old Mutual Glob Investors (Uk) accumulated 0.1% or 80,766 shares. Blackrock Fund Advsr reported 2.91 million shares or 0.04% of all its holdings. Virginia Retirement System Et Al last reported 0.02% of its portfolio in the stock. Assetmark Incorporated accumulated 0% or 5 shares. The New York-based Laurion Capital Ltd Partnership has invested 0.02% in PAREXEL International Corporation (NASDAQ:PRXL). Goldman Sachs has 0.01% invested in the company for 350,677 shares. Prudential Fincl last reported 34,649 shares in the company. Sheets Smith Wealth accumulated 0.09% or 5,032 shares. Wells Fargo & Company Mn last reported 0.01% of its portfolio in the stock. Brown Capital Management Lc, a Maryland-based fund reported 70,996 shares. Ameriprise Inc accumulated 0.03% or 798,388 shares. Capstone Asset Management Company accumulated 0.01% or 5,949 shares. Barclays Public Limited has 0% invested in the company for 8,788 shares. Weaver C Barksdale And reported 154 shares or 0.02% of all its holdings.

Insider Transactions: Since May 24, 2016, the stock had 0 insider buys, and 4 insider sales for $570,931 net activity. $44,086 worth of PAREXEL International Corporation (NASDAQ:PRXL) was sold by Holdener Eduard E.. The insider SCHNEIDER ULF I sold $366,000. $175,125 worth of PAREXEL International Corporation (NASDAQ:PRXL) shares were sold by Saarony Gadi. CALLOW A DANA JR sold $180,120 worth of PAREXEL International Corporation (NASDAQ:PRXL) on Monday, June 13. Shares for $171,600 were sold by Schultz Joshua on Tuesday, August 9.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has a market cap of $3.14 billion. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. It has a 18.49 P/E ratio. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

According to Zacks Investment Research, “Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.”

PRXL Company Profile

PAREXEL International Corporation (PAREXEL), incorporated on January 3, 1983, is a biopharmaceutical outsourcing services company. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

More recent PAREXEL International Corporation (NASDAQ:PRXL) news were published by: Fool.com which released: “PAREXEL International Corporation’s Q1 Report Flops, Shares Sink As Much As 13%” on October 27, 2016. Also Businesswire.com published the news titled: “Bragar Eagel & Squire, P.C. Is Investigating PAREXEL International Corporation …” on November 14, 2016. Bizjournals.com‘s news article titled: “Parexel loses $160M in value after disclosing possible embezzlement” with publication date: September 01, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>